US biopharma AbbVie has agreed to acquire ImmunoGen in a deal which values the company at about $10.1 billion and gives AbbVie access to flagship cancer therapy Elahere...
20.11.2017
- US healthcare giant Johnson & Johnson (J&J) has won another victory in a string of lawsuits claiming its talc-based baby powder causes cancer. The jury in the state of California...
02.11.2017
- A court in the US state of California has reversed a verdict against drugmaker Johnson & Johnson in the ongoing litigation over whether the company’s talc productions can be linked...
08.03.2017
- After losing three earlier lawsuits alleging that its talc powder caused ovarian cancer – which cost it nearly $200 million in damages – US healthcare giant Johnson & Johnson (J&J)...
04.05.2016
- US healthcare giant Johnson & Johnson plans to appeal a US jury’s award of $55 million in damages to Gloria Ristesund, who blamed her ovarian cancer – now in remission – on the...
26.02.2016
- A jury hearing a claim in a Missouri state circuit court against US healthcare giant Johnson & Johnson (J&J) has found the company liable for fraud, negligence and conspiracy in...
07.01.2016
- Germany’s Merck KGaA and Pfizer of the US are collaborating with US biopharmaceutical company Syndax to evaluate a combination of avelumab and entinostat to treat advanced ovarian...
